CCL19 and metabolic dysfunction-associated steatotic liver disease: The CCL19/CCR7 pathway promotes the progression of high-fat-induced IR and obesity (42), and these issues are well-known as risk factors for accelerating the pathogenesis of NAFLD and AS.